Poland· PL-100089965
Slow-Mag B6
A pyridoxine (vit b6) product containing magnesii chloridum hexahydricum + pyridoxini hydrochloridum, registered in Poland by ETHIFARM Sp. z o.o. Spółka Komandytowa. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Pyridoxine (vit b6) is registered in 9 of 19 countries.
Countries holding a registration under ATC A11HA02 (pyridoxine (vit b6)), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Pyridoxine (vit b6) · ATC A11HA02
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of pyridoxine (vit b6) costs, country by country.
Normalised to the WHO defined daily dose (0.16 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pyridoxine (vit b6) · price per daily dose (0.16 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.40
The record
At a glance
URPL (Poland)- Active substance
- Magnesii chloridum hexahydricum + Pyridoxini hydrochloridum
- Manufacturer
- ETHIFARM Sp. z o.o. Spółka Komandytowa
- Country
- Poland (PL)
- ATC code
- A11HA02
- ATC class
- Pyridoxine (vit B6)
- Defined daily dose
- 0.16 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990448418
- gtin05903240495450
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
16 interactions on record for pyridoxine (vit b6).
Graded by severity as the source publishes them — 7 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pyridoxine (vit b6) · interactions on record
16 records
- 7 moderate
- 9 minor
Most severe, free to view
- AltretamineL01XX03moderate
- PhenobarbitalN03AA02moderate
- PhenytoinN03AB02moderate
- LevodopaN04BA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pyridoxine (vit b6) in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMAGNE B6Opella Healthcare Czech s.r.o., Praha
- FranceMAGNE B6 48 mg/5 mg, comprimé enrobéOPELLA HEALTHCARE FRANCE
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Bulgaria · Магне B6
- Czechia · Magne B6
- Estonia · Magne B6
- France · Magne B6, Magnesium/Vitamine B6 Biogaran Conseil
- Greece · Evrima-B6
- Hungary · Magne B6, Magne B6 Forte
- Lithuania · Magne B6
- Latvia · Magne B6, Magne B6 Premium
- Malta · Magnevie B6
- Romania · Magne B6, Magne B6 Forte
- Slovakia · Magne B6
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff0aeb38-191d-455e-a9d9-c6e09c857592 GET /v1/drugs/ff0aeb38-191d-455e-a9d9-c6e09c857592?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki dojelitowe",
"source": "urpl",
"strength": "535 mg + 5 mg",
"packaging": "05909990448418 ¦ OTC ¦ 14490\n50 tabl. w pojemniku\n05903240495450 ¦ OTC ¦ 160181\n50 tabl. w blistrze",
"substance": "Magnesii chloridum 0.535 g + Pyridoxini hydrochloridum (Vitaminum B6) 0.005 g",
"common_name": "Magnesii chloridum hexahydricum + Pyridoxini hydrochloridum",
"pl_product_id": "100089965",
"pozwolenie_nr": "04484",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about pyridoxine (vit b6).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.